4.7 Review

New Therapies of Liver Diseases: Hepatic Encephalopathy

Related references

Note: Only part of the references are listed.
Article Gastroenterology & Hepatology

Efficacy and Safety of Ornithine Phenylacetate for Treating Overt Hepatic Encephalopathy in a Randomized Trial

Robert S. Rahimi et al.

Summary: In this study, no significant difference in time to clinical improvement was found between patients with cirrhosis and HE treated with the ammonia scavenger OP compared to placebo. However, OP appeared to be safe and further testing is recommended for its use in treating hyperammonemia in hospitalized patients with acute or overt HE.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Clinical, neuropsychological and neurophysiological indices and predictors of hepatic encephalopathy (HE)

Chiara Formentin et al.

Summary: The study found that in patients without a history of overt hepatic encephalopathy, neuropsychological and neurophysiological tests can predict the occurrence of hepatic encephalopathy, while in patients with a history of overt hepatic encephalopathy, the severity of liver dysfunction plays a larger role in the development of hepatic encephalopathy.

LIVER INTERNATIONAL (2021)

Review Gastroenterology & Hepatology

Efficacy and safety of albumin infusion for overt hepatic encephalopathy: A systematic review and meta-analysis

Kok Ban Teh et al.

Summary: The systematic review and meta-analysis showed that albumin infusion is beneficial in the treatment and prevention of hepatic encephalopathy. Albumin infusion was associated with reduced risk of OHE and inpatient mortality. Further well-powered randomized trials are needed to confirm these findings.

DIGESTIVE AND LIVER DISEASE (2021)

Article Gastroenterology & Hepatology

A pilot study of golexanolone, a new GABA-A receptor-modulating steroid antagonist, in patients with covert hepatic encephalopathy

Sara Montagnese et al.

Summary: The study showed that golexanolone was well tolerated and associated with improvements in cognitive performance for cirrhotic patients. It had positive effects on sleepiness, attention, and brain wave activity, indicating its therapeutic potential.

JOURNAL OF HEPATOLOGY (2021)

Review Gastroenterology & Hepatology

Polyethylene glycol versus lactulose in the treatment of hepatic encephalopathy: a systematic review and meta-analysis

Gilles Jadd Hoilat et al.

Summary: The study suggests that compared to lactulose, the use of polyethylene glycol in the treatment of hepatic encephalopathy leads to significantly lower HE Scoring Algorithm (HESA) Score, shorter time to resolution of HE, and improved efficacy in patients.

BMJ OPEN GASTROENTEROLOGY (2021)

Article Chemistry, Multidisciplinary

Preclinical evaluation of liposome-supported peritoneal dialysis for the treatment of hyperammonemic crises

Simon Matoori et al.

JOURNAL OF CONTROLLED RELEASE (2020)

Article Gastroenterology & Hepatology

EASL Clinical Practice Guidelines on nutrition in chronic liver disease

JOURNAL OF HEPATOLOGY (2019)

Article Gastroenterology & Hepatology

Hepatic encephalopathy 2018: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)

Sara Montagnese et al.

DIGESTIVE AND LIVER DISEASE (2019)

Editorial Material Gastroenterology & Hepatology

Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis

Jasmohan S. Bajaj et al.

GASTROENTEROLOGY (2019)

Review Medicine, General & Internal

Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis

H. D. Zacharias et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)

Review Medicine, General & Internal

Acetyl-L-carnitine for patients with hepatic encephalopathy

Arturo J. Marti-Carvajal et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)

Article Gastroenterology & Hepatology

L-ornithine L-aspartate in bouts of overt hepatic encephalopathy

Sandeep Singh Sidhu et al.

HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Hepatic encephalopathy: a critical current review

Anna Hadjihambi et al.

HEPATOLOGY INTERNATIONAL (2018)

Article Gastroenterology & Hepatology

Under-dilated TIPS Associate With Efficacy and Reduced Encephalopathy in a Prospective, Non-randomized Study of Patients With Cirrhosis

Filippo Schepis et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)

Article Gastroenterology & Hepatology

Secondary prophylaxis of hepatic encephalopathy in cirrhosis of liver: a double-blind randomized controlled trial of L-ornithine L-aspartate versus placebo

Shivakumar Varakanahalli et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2018)

Article Pharmacology & Pharmacy

Treating hepatic encephalopathy in cirrhotic patients admitted to ICU with sodium phenylbutyrate: a preliminary study

Nicolas Weiss et al.

FUNDAMENTAL & CLINICAL PHARMACOLOGY (2018)

Article Gastroenterology & Hepatology

Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis

Qing Cao et al.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2018)

Review Gastroenterology & Hepatology

Exercise in cirrhosis: Translating evidence and experience to practice

Puneeta Tandon et al.

JOURNAL OF HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

Hepatic encephalopathy: Diagnosis and management

Piero Amodio

LIVER INTERNATIONAL (2018)

Article Gastroenterology & Hepatology

The use of human albumin in patients with cirrhosis: a European survey

Paolo Caraceni et al.

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2018)

Review Gastroenterology & Hepatology

The Effects of Probiotics and Symbiotics on Risk Factors for Hepatic Encephalopathy A Systematic Review

Daniela Viramontes Horner et al.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2017)

Review Gastroenterology & Hepatology

Neuropsychiatric performance in patients with cirrhosis: Who is normal?

Sara Montagnese et al.

JOURNAL OF HEPATOLOGY (2017)

Review Medicine, General & Internal

Branched-chain amino acids for people with hepatic encephalopathy

Lise Lotte Gluud et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)

Review Medicine, General & Internal

Probiotics for people with hepatic encephalopathy

Rohan Dalal et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)

Article Gastroenterology & Hepatology

An educational tool for the prophylaxis of hepatic encephalopathy

Maria Garrido et al.

BMJ OPEN GASTROENTEROLOGY (2017)

Article Gastroenterology & Hepatology

Hospitalizations Due to Cirrhosis: Clinical Aspects in a Large Cohort of Italian Patients and Cost Analysis Report

Marco Di Pascoli et al.

DIGESTIVE DISEASES (2017)

Article Gastroenterology & Hepatology

Efficacy of Nutritional Therapy for Patients With Cirrhosis and Minimal Hepatic Encephalopathy in a Randomized Trial

Sudhir Maharshi et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)

Article Biochemistry & Molecular Biology

GABAA receptor modulating steroid antagonists (GAMSA) are functional in vivo

Maja Johansson et al.

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2016)

Article Gastroenterology & Hepatology

Impact of ornithine phenylacetate (OCR-002) in lowering plasma ammonia after upper gastrointestinal bleeding in cirrhotic patients

Meritxell Ventura-Cots et al.

THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)

Article Gastroenterology & Hepatology

GR3027 antagonizes GABAA receptor-potentiating neurosteroids and restores spatial learning and motor coordination in rats with chronic hyperammonemia and hepatic encephalopathy

Maja Johansson et al.

AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2015)

Article Gastroenterology & Hepatology

Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis

J. S. Bajaj et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)

Letter Gastroenterology & Hepatology

Quick Diagnosis of Hepatic Encephalopathy: Fact or Fiction?

Sara Montagnese et al.

HEPATOLOGY (2015)

Article Gastroenterology & Hepatology

Rifaximin Is Safe and Well Tolerated for Long-term Maintenance of Remission From Overt Hepatic Encephalopathy

Kevin D. Mullen et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)

Article Gastroenterology & Hepatology

Randomized, Double-Blind, Controlled Study of Glycerol Phenylbutyrate in Hepatic Encephalopathy

Don C. Rockey et al.

HEPATOLOGY (2014)

Article Neurosciences

Comparative Neuroprotective Effects of Dexamethasone and Minocycline during Hepatic Encephalopathy

Maha Gamal et al.

NEUROLOGY RESEARCH INTERNATIONAL (2014)

Article Gastroenterology & Hepatology

l-ornithine-l-aspartate for hepatic encephalopathy in patients with cirrhosis: A meta-analysis of randomized controlled trials

Ming Bai et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)

Article Endocrinology & Metabolism

Excessive daytime sleepiness and hepatic encephalopathy: it is worth asking

Michele De Rui et al.

METABOLIC BRAIN DISEASE (2013)

Article Endocrinology & Metabolism

Muscle depletion increases the risk of overt and minimal hepatic encephalopathy: results of a prospective study

Manuela Merli et al.

METABOLIC BRAIN DISEASE (2013)

Article Endocrinology & Metabolism

Ornithine phenylacetate revisited

Maria Jover-Cobos et al.

METABOLIC BRAIN DISEASE (2013)

Article Endocrinology & Metabolism

Acetyl-L-carnitine in hepatic encephalopathy

Michele Malaguarnera

METABOLIC BRAIN DISEASE (2013)

Review Nutrition & Dietetics

A systematic review and meta-analysis of the use of oral zinc in the treatment of hepatic encephalopathy

Norberto C. Chavez-Tapia et al.

NUTRITION JOURNAL (2013)

Article Gastroenterology & Hepatology

Oral Acetyl-L-Carnitine treatment in hepatic encephalopathy: view of evidence-based medicine

Qian Jiang et al.

ANNALS OF HEPATOLOGY (2013)

Article Gastroenterology & Hepatology

Induced hyperammonemia may compromise the ability to generate restful sleep in patients with cirrhosis

Alessia Bersagliere et al.

HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

Late evening snack: Exploiting a period of anabolic opportunity in cirrhosis

Cynthia D. Tsien et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)

Article Gastroenterology & Hepatology

A randomized controlled trial comparing lactulose, probiotics, and L-ornithine L-aspartate in treatment of minimal hepatic encephalopathy

Vibhu Vibhas Mittal et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2011)

Article Gastroenterology & Hepatology

Prophylaxis of hepatic encephalopathy in acute variceal bleed: A randomized controlled trial of lactulose versus no lactulose

Praveen Sharma et al.

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2011)

Article Medicine, General & Internal

Rifaximin Treatment in Hepatic Encephalopathy

Nathan M. Bass et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Gastroenterology & Hepatology

Secondary Prophylaxis of Hepatic Encephalopathy: An Open-Label Randomized Controlled Trial of Lactulose Versus Placebo

Barjesh Chander Sharma et al.

GASTROENTEROLOGY (2009)

Article Gastroenterology & Hepatology

Normal protein diet for episodic hepatic encephalopathy:: results of a randomized study

J Córdoba et al.

JOURNAL OF HEPATOLOGY (2004)

Article Gastroenterology & Hepatology

Liver transplantation improves hepatic myelopathy: Evidence by three cases

K Weissenborn et al.

GASTROENTEROLOGY (2003)